Lintaptin-5

Linagliptin

Linagliptin: Improved Diabetes Control in Type 2
It has asked that Bayer HealthCare's linagliptin be qualified as HIDC with special reference to the dipeptidyl peptidase-4 enzymes, deemed to inactivate antidiabetic DPP-4 inhibitor class, that is, Gliptins. In this way, linagliptin may be useful in governing adult Diabetes Mellitus type II individuals suffering hyperglycemia when exercise and dietary management meeting alone is quite inadequate. Diverse from the others of its league, it offers a favorable advantage to patients with mild-to-moderate kidney impairment because of over 80% of renal concerns ridding it.

8 The Key Therapeutic Benefits
Effective at HbA1c reduction: This can make improvement of long-term blood sugar control and significant reduction in postprandial glucose spikes.
Weight Neutrality: May or may not remarkably increase body weight.
Hypoglycemia Risk: Alone, the risk of hypoglycemia is low.
Decreasing Need for Dose Changes: Usually, the dose of linagliptin in renal impairment does not need to be adjusted.

How it Works
Linagliptin inhibits the breakdown of incretin hormones produced by the gut postprandially. These incretins signal to the pancreas to excrete more insulin and signal to the liver to stop its glucose production. DPP-4 generally breaks down these hormones quickly. Linagliptin, being an inhibitor for DPP-4, allows for these incretins to be active for a longer time, thereby keeping one's blood sugar level in check.

Usage and Safety Guidelines
Dosage: The majority of patients begin with an initial dosage of 5 mg. This is done once per day.
Flexibility: Administer the tablet with or without food. Nonetheless, linagliptin should be taken at the same time each day for consistent levels in the body.
Administration: Swallowed the tablet whole with a glass of water. Not chewing the tablet. No breaking down.

Abscesses
Most humans tolerate linagliptin well. In some cases, people may experience the following:
Running nose or having a sore throat on cold weather and fever.
Coughing.
Headache.
Mild backache.

Alarming symptoms of impending serious tissue cellulitis are abdominal pain, about mid-right upper quadrant, or referred to the back; please immediately stop the Linagliptin therapy and seek medical advice, as these side effects could lead to pancreatitis.

Linagliptin FAQs
Regrettably, not for Type I Diabetes. Linagliptin is there for Type 2 Diabetes whose major problem is an insulin fault mechanism. Linagliptin is nowhere suitable for the management of Type 1 Diabetes nor for en route to diabetic ketoacidosis.

Q: What should one do if somebody misses their dose?
A: Linagliptin doses are supposed to be taken with skipped doses until the standard schedule resumes. Under no circumstance should one take two tablets at once to compensate for a missed dose.

Q: Can I combine Linagliptin with my diabetic drugs?
A: Usually, they are combined with metformin, sulphonylureas, generally Insulins. However, the combinations of linagliptin with Insulins or sulphonylureas increase the chance of hypoglycemia; hence the need to modify their dosages properly protects against severe hypoglycemia.

Q: Is it safe for me to consume liquor while on linagliptin?
A: In moderation, yes. Alcohol use may disrupt blood sugar control and further raise the risk of pancreatitis. Discussing alcohol consumption with your doctor is the best way to go.

Q: How long must one wait to see an effect from linagliptin?
A: It will start showing an effect on your blood sugar readings in about a week. However, full assessment of your HbA1c levels can be done usually after 2-3 months of steady use.

Quick Entry on the Product
Properties of Interest
Details

Drug Class
DPP-4 Inhibitor (Gliptin)

Main Indication
Type 2 Diabetes Mellitus

Recommended Dosage
5 mg daily

Storage
Store below 30°C away from moisture